Will These Marijuana Stocks Reach New Highs In 2021?
When it comes to finding marijuana stocks to watch, there are plenty of options. Most investors tend to focus on the top two or three big-name cannabis stocks. This includes Green Thumb Industries Inc(OTC:GTBIF) and Cronos Group Inc. (NASDAQ:CRON). But, this is simply the tip of the iceberg when it comes to pot stocks. These companies fit into a category known as pure-play marijuana stocks. This simply means that they work by producing and providing large quantities of cannabis. Companies like these have come into the spotlight in the past few months as they are the more progressive businesses in the industry. As we move down the list, next is MSOs and ESPs. These companies tend to be grouped together as they operate within a similar sector of the cannabis industry.
[Read More]
-
Will Mexico Take Over The Cannabis Industry After Going Legal
-
Are These Marijuana Stocks Built For The Future Of The Cannabis Industry
On one hand, we have MSOs or multi-state operators. These are cannabis companies that have a large portfolio of dispensaries that either span certain select states or a broad number of states. On the other hand, we have ESPs or extraction service providers. These businesses work by producing large quantities of cannabis oils that are extracted from the marijuana or hemp plant. Because the demand for cannabis concentrates has shot up in the past year, these companies are continuing to be in focus. ESPs and MSOs tend to show greater chances of profitability than pure-play pot stocks simply because of their margins. Also, there are quite a few pot stocks to watch within these categories. Last on the list comes ancillary marijuana stocks.
What Is The Next Step For Marijuana Stocks and The Cannabis Industry
This could be anything from money transport services to REITs and more. These companies can often be less volatile than other pot stocks which can be due to their involvement in industries outside of cannabis. Well, this is in no way a definitive list, it is a great place to start. The next step in finding a cannabis stock to buy is doing as much research as one can. The best investors are the ones with the most information at hand. And with the power of the internet, everyone has the same access to press releases and company financials. With all of this in mind, here are four-pot stocks to watch.
Marijuana Stocks To Watch
Canopy Growth Corporation (NASDAQ:CGC)
GW Pharmaceuticals plc (NASDAQ:GWPH)
Canopy Growth Corporation
From the initial start of 2020 Canopy Growth Corporation has been one of many marijuana stocks fighting its way back up in the market. February 20th to March 18th CGC stock dropped 56%. From this downtrend, CGC stock began to rise to reach a share price of $15.16 on March 26th. This made for a 55% increase in trading. Moving forward for the majority of 2020 like most pot stocks Canopy has been fighting market volatility all while still seeing gains. 
If you look at this past October when CGC stock increased by 33% for that whole month. This was also the start of the company consistently moving higher in the market with dipping down too much. During the whole month of November, CGC stock was able to sustain its upward push for a monthly increase of 37%. Currently in the month of January CGC stock has shot up by 27%. As the company continues to build more momentum many investors still see Canopy Growth Corporation as a marijuana stock to watch.
[Read More]
-
Marijuana Penny Stock To Watch This Week 2 Pot Stocks With Potential Gains
-
2 Marijuana Stocks To Watch With Cannabis Stocks Gaining In The Market
GW Pharmaceuticals plc
For those who don’t know about GW Pharmaceuticals plc, this marijuana stock has been at the forefront of cannabinoid research and development. The company first came to be back in 1998 and since then has been focused on producing and commercializing treatments through the use of cannabinoids or CBD. Its all-star product, EPIDIOLEX which is used to treat treatment of seizures associated with Lennox-Gastaut syndrome Dravet syndrome, or tuberous sclerosis complex.
So far EPIDIOLEX has generated large amounts of revue for the company as well as being the first FDA-approved CBD treatment. During the month of November, GWPH Shot up 56% dipping back down the following month. During the month of December, GWPH stock dipped down 15% before shooting back up 18% in January. This increase in momentum is showing investors that GW Pharmaceuticals still has growth potential as a marijuana stock to watch.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
